Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts

Gynecologic Oncology

Volumn 93, Issue 2, 2004, Pages 315-319

  Woo, Michelle M M ^a   Gilks, C Blake ^a   Verhage, Harold G ^b   Longacre, Teri A ^c   Leung, Peter C K ^a   Auersperg, Nelly ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ILLINOIS   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Differentiation; Epithelial inclusion cysts; Marker; Ovarian cancer; Oviductal glycoprotein; Serous borderline tumors

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN; OVIDUCT SPECIFIC GLYCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CYSTADENOMA; DUODENUM; ENDOMETRIOID CARCINOMA; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; HUMAN TISSUE; ILEUM; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; OVARY TUMOR; OVIDUCT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SALIVARY GLAND; UTERINE TUBE MUCOSA;

ADENOCARCINOMA; CELL DIFFERENTIATION; EPITHELIAL CELLS; FEMALE; GLYCOPROTEINS; HUMANS; MIXED TUMOR, MULLERIAN; NEOPLASM STAGING; OVARIAN CYSTS; OVARIAN NEOPLASMS; OVARY; TUMOR MARKERS, BIOLOGICAL;

EID: 1942445023     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.01.047     Document Type: Article

References (31)

1. American Cancer Society Cancer facts and figures 2003. 2003;American Cancer Society Inc. Atlanta.
2. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. C.A. Cancer J. Clin. 53:2003;5-26.
3. Scully R.E. Influence of origin of ovarian cancer on efficacy of screening. Lancet. 355:2000;1028-1029.
4. Auersperg N., Wong A.S., Choi K.C., Kang S.K., Leung P.C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22:2001;255-288.
5. Scully R.E., Young R.H., Clement P.B. Atlas of tumor pathology, third series, fascicle 23. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. 1998;Armed Forces Institute of Pathology, Washington (DC).
6. Maines-Bandiera S.L., Auersperg N. Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int. J. Gynecol. Pathol. 16:1997;250-255.
7. Sundfeldt K., Piontkewitz Y., Ivarsson K., Nilsson O., Hellberg P., Brannstrom M.et al. E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int. J. Cancer. 74:1997;275-280.
8. Davies B.R., Worsley S.D., Ponder B.A. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology. 32:1998;69-80.
9. Bast R.C. Jr., Xu F.J., Yu Y.H., Barnhill S., Zhang Z., Mills G.B. CA 125: the past and the future. Int. J. Biol. Markers. 13:1998;179-187.
10. Hellstrom I., Raycraft J., Hayden-Ledbetter M., Ledbetter J.A., Schummer M., McIntosh M.et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 63:2003;3695-3700.
11. Mazurek A., Niklinski J., Laudanski T., Pluygers E. Clinical tumor markers in ovarian cancer. Eur. J. Cancer Prev. 7:1998;23-35.
12. Rapisarda J.J., Mavrogianis P.A., O'Day-Bowman M.B., Fazleabas A.T., Verhage H.G. Immunological characterization and immunocytochemical localization of an oviduct-specific glycoprotein in the human. J. Clin. Endocrinol. Metab. 76:1993;1483-1488.
13. Arias E.B., Verhage H.G., Jaffe R.C. Complementary deoxyribonucleic acid cloning and molecular characterization of an estrogen-dependent human oviductal glycoprotein. Biol. Reprod. 51:1994;685-694.
14. Leese H.J., Tay J.I., Reischl J., Downing S.J. Formation of fallopian tubal fluid: role of a neglected epithelium. Reproduction. 121:2001;339-346.
15. O'Day-Bowman M.B., Mavrogianis P.A., Fazleabas A.T., Verhage H.G. A human oviduct-specific glycoprotein: synthesis, secretion, and localization during the menstrual cycle. Microsc. Res. Tech. 32:1995;57-69.
16. Jaffe R.C., Arias E.B., O'Day-Bowman M.B., Donnelly K.M., Mavrogianis P.A., Verhage H.G. Regional distribution and hormonal control of estrogen-dependent oviduct-specific glycoprotein messenger ribonucleic acid in the baboon (Papio anubis). Biol. Reprod. 55:1996;421-426.
17. Kabawat S.E., Bast R.C. Jr., Bhan A.K., Welch W.R., Knapp R.C., Colvin R.B. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int. J. Gynecol. Pathol. 2:1983;275-285.
18. Lapensee L., Paquette Y., Bleau G. Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil. Steril. 68:1997;702-708.
19. Verhage H.G., Fazleabas A.T., Donnelly K. The in vitro synthesis and release of proteins by the human oviduct. Endocrinology. 122:1988;1639-1645.
20. Boice M.L., McCarthy T.J., Mavrogianis P.A., Fazlebas A.T., Verhage H.G. Localization of oviductal glycoproteins within the zona pellucida and perivitelline space of ovulated ova and early embryos in baboons (Papio anubis). Biol. Reprod. 43:1990;340-346.
21. Boatman D.E., Magnoni G.E. Identification of a sperm penetration factor in the oviduct of the golden hamster. Biol. Reprod. 52:1995;199-207.
22. O'Day-Bowman M.B., Mavrogianis P.A., Reuter L.M., Johnson D.E., Fazleabas A.T., Verhage H.G. Association of oviduct-specific glycoproteins with human and baboon (Papio anubis) ovarian oocytes and enhancement of human sperm binding to human hemizonae following in vitro incubation. Biol. Reprod. 54:1996;60-69.
23. Schmidt A., Mavrogianis P.A., O'Day-Bowman M.B., Jaffe R.C., Verhage H.G. Characterization of antibodies generated against a conserved portion of oviductal glycoprotein (OGP) and endogenous hamster OGP and their ability to decrease sperm binding to the zona pellucida in vitro. Am. J. Reprod. Immunol. 38:1997;377-383.
24. Alkushi A., Irving J., Hsu F., Dupuis B., Liu C.L., Rijn M.et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch. 442:2003;271-277.
25. Verhage H.G., Mavrogianis P.A., O'Day-Bowman M.B., Schmidt A., Arias E.B., Donnelly K.M.et al. Characteristics of an oviductal glycoprotein and its potential role in the fertilization process. Biol. Reprod. 58:1998;1098-1101.
26. Hu J., Khanna V., Jones M.M.W., Surti U. Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet. Cytogenet. 139:2002;13-23.
27. Verhage H.G., Fazleabas A.T., Mavrogianis P.A., O'Day-Bowman M.B., Schmidt A., Arias E.B.et al. Characteristics of an oviductal glycoprotein and its potential role in fertility control. J. Reprod. Fertil., Suppl. 51:1997;217-226.
28. McCauley T.C., Buhi W.C., Wu G.M., Mao J., Caamano J.N., Didion B.A.et al. Oviduct-specific glycoprotein modulates sperm-zona binding and improves efficiency of porcine fertilization in vitro. Biol. Reprod. 69:2003;828-834.
29. O'Day-Bowman M.B., Mavrogianis P.A., Minshall R.D., Verhage H.G. In vivo versus in vitro oviductal glycoprotein (OGP) association with the zona pellucida (ZP) in the hamster and baboon. Mol. Reprod. Dev. 62:2002;248-256.
30. Staros A.L., Killian G.J. In vitro association of six oviductal fluid proteins with the bovine zona pellucida. J. Reprod. Fertil. 112:1998;131-137.
31. Buhi W.C. Characterization and biological roles of oviduct-specific, oestrogen-dependent glycoprotein. Reproduction. 123:2002;355-362.